A new research paper was published in Oncotarget entitled "Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer."
Nov 08, 2022
0
2
MicroRNA (miRNA) can be used as a biomarker to predict which patients are likely to face breast cancer recurrence and mortality, according to study results published online ahead of print in the Journal of the American College ...
Nov 04, 2022
0
21
Patients with early-stage breast cancer who had a pathologic complete response (pCR) to neoadjuvant chemotherapy may be able to skip surgery and receive standard radiation treatment with a low chance of disease recurrence, ...
Oct 25, 2022
0
42
Approximately 9,000 women are diagnosed with breast cancer each year in Sweden, a number that has been steadily increasing since the 1990s. However, as the prognosis for breast cancer has improved, more and more women can ...
Oct 17, 2022
0
2
Both proportions and odds of pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) are numerically lower in men with breast cancer (BC) versus women with BC for each tumor subtype, according to a study published ...
Oct 06, 2022
0
5
Gastric cancer is a common malignant tumor that originates from the gastric mucosal epithelium. Being insidious and non-specific, the early-stage symptoms of the cancer are similar to that of chronic diseases such as gastritis ...
Sep 28, 2022
0
1
Black women treated with neoadjuvant endocrine therapy for breast cancer were more likely to benefit than white women if treated at an earlier disease stage but less likely to benefit than white women if treated at a later ...
Sep 16, 2022
0
5
For high-risk patients with prostate cancer, treatment with novel hormonal agents (NHAs) followed by surgery can reduce the risk of recurrent and progressive cancer, compared to initial treatment with surgery, suggests a ...
Sep 12, 2022
0
41
Patients with high-risk melanoma who received the immunotherapy drug pembrolizumab both before and after surgery to remove cancerous tissue had a significantly lower risk of their cancer recurring than similar patients who ...
Sep 11, 2022
0
39
New research in the September 2022 issue of Journal of the National Comprehensive Cancer Network finds the use of positron emission tomography (PET) with 18-fluorodeoxyglucose (FDG) tracer adds significant prognostic benefit ...
Sep 08, 2022
0
42
